ZNF252 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 6.56450449554313E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.08109973698356E-10 |
Normal-vs-Stage2 |
6.58679999987477E-07 |
Normal-vs-Stage3 |
2.78800005304447E-09 |
Normal-vs-Stage4 |
7.76740000000276E-05 |
Stage1-vs-Stage2 |
8.157200E-01 |
Stage1-vs-Stage3 |
3.015000E-01 |
Stage1-vs-Stage4 |
9.026200E-01 |
Stage2-vs-Stage3 |
5.175600E-01 |
Stage2-vs-Stage4 |
7.582400E-01 |
Stage3-vs-Stage4 |
3.819200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.69779762365852E-11 |
Normal-vs-AfricanAmerican |
1.64159996707269E-09 |
Normal-vs-Asian |
1.645840E-04 |
Caucasian-vs-AfricanAmerican |
6.570400E-01 |
Caucasian-vs-Asian |
6.599000E-01 |
AfricanAmerican-vs-Asian |
4.857200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
7.12307990369254E-12 |
Normal-vs-Female |
4.37760000471243E-08 |
Male-vs-Female |
1.366750E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
2.54659999754381E-08 |
Normal-vs-Extreme_Weight |
5.75309799799584E-11 |
Normal-vs-Obese |
4.46159997835593E-10 |
Normal-vs-Extreme_Obese |
6.647600E-04 |
Normal_Weight-vs-Extreme_Weight |
5.913600E-01 |
Normal_Weight-vs-Obese |
6.943600E-01 |
Normal_Weight-vs-Extreme_Obese |
6.105400E-01 |
Extreme_Weight-vs-Obese |
2.748600E-01 |
Extreme_Weight-vs-Extreme_Obese |
3.934200E-01 |
Obese-vs-Extreme_Obese |
7.120600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.280200E-02 |
Normal-vs-Age(41-60Yrs) |
1.72960001876277E-09 |
Normal-vs-Age(61-80Yrs) |
2.40549802299483E-11 |
Normal-vs-Age(81-100Yrs) |
1.93420000016431E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.374000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.422000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.395000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.314600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.184600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.084800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
3.03179703564638E-12 |
Normal-VS-Type2 PRCC |
7.31340543680403E-11 |
Normal-VS-KIRP CIMP |
3.70930000004321E-06 |
Normal-VS-Unclassified PRCC |
1.916400E-03 |
Type1 PRCC-VS-Type2 PRCC |
2.156400E-01 |
Type1 PRCC-VS-KIRP CIMP |
6.250000E-01 |
Type1 PRCC-VS-Unclassified PRCC |
3.382000E-01 |
Type2 PRCC-VS-KIRP CIMP |
9.408800E-01 |
Type2 PRCC-VS-Unclassified PRCC |
1.481550E-01 |
KIRP CIMP-VS-Unclassified PRCC |
2.507400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.05304653885696E-12 |
Normal-vs-N1 |
2.38340003289039E-09 |
Normal-vs-N2 |
7.55820000000185E-05 |
N0-vs-N1 |
5.159200E-01 |
N0-vs-N2 |
4.779800E-01 |
N1-vs-N2 |
2.701600E-01 |
|
|